Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes.

By B. Laferrère, J. Teixeira, J. McGinty, Hao Tran, Joseph R Egger, Antonia Colarusso, Betty Kovack, B. Bawa, Ninan Koshy, Hongchan Lee and 2 more. Journal of Clinical Endocrinology and Metabolism, 2008

689 citations recorded by the source corpus.

Subfields: Nutrition and Dietetics, Surgery

View Paper: https://www.semanticscholar.org/paper/ef4a475043d4ad730f6498a93c90c103160627ba

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Surgery

1. Gerald I. Shulman
2. V. Samuel
3. J. Cawley
4. Chad D Meyerhoefer

Citations in the corpus

• Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol (2011, background): “Increased glucagon-like peptide-1 secretion following bariatric surgery compared with a hypocaloric diet has been reported, but the oral glucose load used in the presence of a gastroenterostomy is likely to explain the early rapid rise in both plasma glucose and the incretin, occasionally with the s”
• CLINICAL PRACTICE GUIDELINES FOR THE PERIOPERATIVE NUTRITIONAL, METABOLIC, AND NONSURGICAL SUPPORT OF THE BARIATRIC SURGERY PATIENT—2013 UPDATE: COSPONSORED BY AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, THE OBESITY SOCIETY, AND AMERICAN SOCIETY FOR METABOLIC & BARIATRIC SURGERY (2013, background): “[68] Laferrere B, Teixeira J, McGinty J, et al.”
• An Endocrine Society Clinical Practice Guideline Endocrine and Nutritional Management of the Post-Bariatric Surgery Patient: (2010, background): “The long-term effects of these bypass operations appear to include both weight loss-dependent and -independent effects (139).”
• Interdisciplinary European Guidelines on Metabolic and Bariatric Surgery (2014, background): “The focus when treating obese patients is gradually shifting from the primary goal of weight loss outcomes to the metabolic effects of the operations (EL A, B, C and D) [115–127].”